<SEC-DOCUMENT>0002109299-26-000004-index.html : 20260217
<SEC-HEADER>0002109299-26-000004.hdr.sgml : 20260217
<ACCEPTANCE-DATETIME>20260217165506
ACCESSION NUMBER:		0002109299-26-000004
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260213
FILED AS OF DATE:		20260217
DATE AS OF CHANGE:		20260217

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bhalla Narinder Pal
		CENTRAL INDEX KEY:			0002109299
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41855
		FILM NUMBER:		26643086

	MAIL ADDRESS:	
		STREET 1:		205 S FAIRVILLE ROAD
		CITY:			CHADDS FORD
		STATE:			PA
		ZIP:			19317

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexeo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001907108
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				854012572
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 547-9879

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-02172026_040201.xml
<TEXT>
Document 1 - file: form4-02172026_040201.html

Document 1 - RAW XML: form4-02172026_040201.xml

</DOCUMENT>
</SEC-DOCUMENT>